Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Depreciation & Amortization (CF) (2016 - 2025)

STRATA Skin Sciences' Depreciation & Amortization (CF) history spans 14 years, with the latest figure at $864000.0 for Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) fell 30.27% year-over-year to $864000.0; the TTM value through Sep 2025 reached $4.5 million, down 9.67%, while the annual FY2024 figure was $5.0 million, 10.53% down from the prior year.
  • Depreciation & Amortization (CF) for Q3 2025 was $864000.0 at STRATA Skin Sciences, down from $1.2 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $3.5 million in Q4 2022 and bottomed at $481000.0 in Q1 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $1.2 million (2024), against an average of $1.3 million.
  • The largest annual shift saw Depreciation & Amortization (CF) skyrocketed 174.64% in 2022 before it plummeted 63.22% in 2023.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $2.2 million in 2021, then surged by 60.97% to $3.5 million in 2022, then tumbled by 63.22% to $1.3 million in 2023, then decreased by 3.83% to $1.2 million in 2024, then decreased by 29.76% to $864000.0 in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Depreciation & Amortization (CF) are $864000.0 (Q3 2025), $1.2 million (Q2 2025), and $1.2 million (Q1 2025).